DarioHealth Corp. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
DarioHealth Corp. (DRIO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $61.02 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-08-11
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2026-03-31 was $62.73, a 1492.13% increase year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2025-03-31 was $3.94, a 71.90% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $14.02, a 48.51% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $27.23, a 188.45% increase year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $81.94, a 586.26% increase from fiscal 2024.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $11.94, a 60.87% decline from fiscal 2023.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $30.51, a 67.18% increase from fiscal 2022.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $18.25, a 58.43% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $61.02 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | $62.73 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $81.94 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $94.89 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $5.14 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | $3.94 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $11.94 10-K · filed 2025-03-10 | |||
| 2024-09-30 | $14.30 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $20.03 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $14.02 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | $30.51 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $29.85 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $27.96 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | $27.23 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $18.25 10-K · filed 2023-03-09 | |||
| 2022-09-30 | $17.74 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $17.47 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $9.44 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $43.90 10-K · filed 2022-03-22 | |||
| 2021-09-30 | $49.33 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $10.02 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $16.86 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $41.96 10-K · filed 2021-03-09 | |||
| 2020-09-30 | $33.24 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | $44.09 10-Q · filed 2020-08-12 | |||
| 2020-03-31 | $30.57 10-Q · filed 2020-05-12 | |||
| 2019-12-31 | $63.22 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $4.06 10-Q · filed 2019-10-28 | |||
| 2019-06-30 | $4.36 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $3.53 10-Q · filed 2019-05-13 | |||
| 2018-12-31 | $2.38 10-K · filed 2019-03-25 | |||
| 2017-12-31 | $36.02 10-K · filed 2018-03-19 | |||
| 2016-12-31 | $6.23 10-K · filed 2017-03-22 | |||
| 2015-12-31 | $7.78 10-K · filed 2016-02-08 | |||
| 2015-09-30 | $8.05 10-Q · filed 2015-11-13 | |||
| 2015-06-30 | $7.07 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | $5.83 10-Q · filed 2015-05-14 | |||
| 2014-12-31 | $11.21 10-K · filed 2015-03-24 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |